Your browser doesn't support javascript.
loading
Investigating the cytotoxic and apoptotic effects of sunitinib upon K-562 chronic myelogenous leukemia cell line and assessment of gene profiling.
Ozkan, Melda Comert; Kaymaz, Burcin Tezcanli; Gunes, Ajda; Can, Buket Kosova; Soyer, Nur Akad; Yilmaz, Asu Fergun; Vural, Filiz; Sahin, Fahri; Saydam, Guray.
Afiliación
  • Ozkan MC; Department of Hematology, Ege University, School of Medicine, Izmir, Turkey.
  • Kaymaz BT; Department of Medical Biology, Ege University, School of Medicine, Izmir, Turkey.
  • Gunes A; Department of Hematology, Ege University, School of Medicine, Izmir, Turkey.
  • Can BK; Department of Medical Biology, Ege University, School of Medicine, Izmir, Turkey.
  • Soyer NA; Department of Hematology, Ege University, School of Medicine, Izmir, Turkey.
  • Yilmaz AF; Department of Hematology, Ege University, School of Medicine, Izmir, Turkey.
  • Vural F; Department of Hematology, Ege University, School of Medicine, Izmir, Turkey.
  • Sahin F; Department of Hematology, Ege University, School of Medicine, Izmir, Turkey.
  • Saydam G; Department of Hematology, Ege University, School of Medicine, Izmir, Turkey.
J Cancer Res Ther ; 16(1): 150-156, 2020.
Article en En | MEDLINE | ID: mdl-32362626
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Biomarcadores de Tumor / Regulación Neoplásica de la Expresión Génica / Apoptosis / Proliferación Celular / Sunitinib / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Cancer Res Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2020 Tipo del documento: Article País de afiliación: Turquía
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Biomarcadores de Tumor / Regulación Neoplásica de la Expresión Génica / Apoptosis / Proliferación Celular / Sunitinib / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Cancer Res Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2020 Tipo del documento: Article País de afiliación: Turquía